Ovarian cancer Stage IIIC. Consequences of treatment level on overall and progression-free survival

European Journal of Gynaecological Oncology

Volumn 27, Issue 3, 2006, Pages 209-214

  Oksefjell, H ^a   Sandstad, B ^a   Trope, C ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Ovarian cancer; Survival; Treatment level

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL; PLATINUM;

ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; GYNECOLOGIC CANCER; HEALTH CARE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PROGNOSIS; STATISTICAL ANALYSIS; TREATMENT PLANNING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 33745469764     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Cancer in Norway 2001. The Cancer Registry of Norway. Oslo, Norway.
2. Pecorelli S., Benedet J.L., Creasman W.T., Stephard J.H., Petterson F.: "Annual report on the results of treatment in gynecological cancer". Vol 23. Oxford, U.K., International Federation of Gynecology and Obstetrics, 1998.
3. Bjørge T., Engeland A., Sundfør K., Trope C.: "Prognosis of 2800 patients With epithelial ovarian canser diagnosed during 1975-94 and treated at the Norwegian Radium Hospital". Acta Obstet. Gynecol. Scand., 1998, 77, 777.
4. Griffith C.T.: "Surgical resection of tumor bulk in the primary treatment of ovarian carsinoma". Natl. Cancer Inst. Monogr., 1975, 42, 101.
5. Aure J.C., Hoeg K., Kolstad P.: "Clinical and histologic studies of ovarian carsinoma. Long-term follow-up of 990 cases". Obstet. Gynecol., 1971, 37, 1.
6. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble L.E., Montz F.J.: "Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis". J. Clin. Oncol., 2002, 20, 1248.
7. Eisenkop S.M., Spirtos N.M., Friedman R.L. et al.: "Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian canser: a prospective study". Gynecol. Oncol., 2003, 90, 390.
8. van der Burg M.E., van Lent M., Buyse M. et al.: "The effect of debulking surgery after induction chemoterapi on the prognosis in advanced epitelial ovarian cancer". N. Engl. J. Med., 1995, 332, 629.
9. Berek J.S.: "Intervall debulking of epithelial ovarian cancer: an interim measure". N. Eng. J. Med., 1995, 332, 675.
10. Rose P.G., Nerenstone S., Brady M.F. et al. for GOG: "Secondary surgical cytoreduction for advanced ovarian carcinoma". N. Engl. J. Med., 2004, 531, 24.
11. Kehoe S., Powell J., Wilson S., Woodman C.: "The influence of the operating surgeon's spesialisation on patients survival in ovarian carsinoma". Br. J. Cancer, 1994, 70, 1014.
12. Tingulstad S., Skjeldestad F.E., Hagen B.: "The effect of centralization of primary surgery on survival in ovarian cancer patients". Obstet. Gynecol., 2003, 102, 499.
13. Junor E.J., Hole D.J., McNulty L., Mason M., Young J.: "Spesialist gynecologists and survival outcome in ovarian cancer: a Scottish National Study of 1966 patients". Br. J. Obstet. Gynecol., 1999, 106, 1130.
14. Olaitan A., Weeks J., Mocroft A., Smith J., Howe K., Murdich J.: "The surgical management of women with ovarian cancer in the south west of England". Br. J. Cancer, 2001, 85, 1824.
15. Gillis C.R., Hole D.J., Still R.M., Davis J., Kaye Sb.: "Medical audit, cancer registration, and survival in ovarian cancer". Lancet, 1991, 337, 611.
16. Paulsen T., Kjærheim K., Kærn J., Tretli S., Trope C.: "Improved short-term survival for advanced ovarian, tubar and peritonal cancer patients operated at teaching hospitals". Int. J. Gynecol. Cancer, 2006, 16 (suppl. 1), 11.
17. Goldie J.H., Coldman A.J.: "A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate". Cancer Treat. Rep., 1979, 63, 1727.
18. Geide K.C., Kieser K., Dodge J., Rosen B.: "Who should operate on patients with ovarian cancer? An evidence-based review". Gynecol. Oncol., 2005, 99, 447.